Trial Information

Summary: An Efficacy and Safety Study of Reslizumab (CTx55700) in the Treatment of Poorly Controlled Asthma in Subjects with Eosinophilic Airway Inflammation

Do You Suffer From Asthma?


If you have moderate or severe asthma, find out if you qualify for a clinical research study for an investigational asthma medication. You may be eligible if you:

• Take Inhaled Corticosteroids (i.e. Flovent 220 or Advair 500/50) and at least one otherasthma medication
• Are between the ages of 18-75

We are recruiting subjects now! Participants will be seen by a medical doctor and receive study medication or placebo (contains no active medication) at no cost. It involves 7 study visits over an 18-week period and involves 4 infusions. Compensation is up to $600. For more information, please contact:


[Asthma Research Center, 1-888-99-ASTHMA or www.asthmaBWH.org or ARC@Partners.Org]

Contact:

Crystal Wesockes
MGH - Massachusetts General Hospital
55 Fruit Street
Boston, MA 02114
Telephone: 617-732-8201
Email:

If you would like to learn more about participating in this study, please send an e-mail message using the form below.

*Subject:

Name:

Address:

City:

State:

*Zip:

*Country:

Phone:

*Email address:

Message:

Please note: A number of commercial online services display an error message after you click on Send. Please be assured that your message has been received.

This site is run by CenterWatch, a publishing company that focuses on the clinical trials industry. The information provided in this service is designed to help patients find clinical trials that may be of interest to them, and to help patients contact the centers conducting the research. CenterWatch is neither promoting this research nor involved in conducting any of these trials.

Trial listings updated: November 17, 2008 at 2:56:10 PM


Back to Centerwatch Trial Listing by Location


Additional resources
in this illness area

Copyright © 1995 - 2008, CenterWatch
All Rights Reserved

This site was developed in association with Illumina Interactive, Boston, MA